InspireMD Files 8-K, No New Material Info

Ticker: NSPR · Form: 8-K · Filed: Jun 13, 2024 · CIK: 1433607

Inspiremd, INC. 8-K Filing Summary
FieldDetail
CompanyInspiremd, INC. (NSPR)
Form Type8-K
Filed DateJun 13, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: regulation-fd, filing

Related Tickers: NSPR

TL;DR

NSPR filed an 8-K, but it's just a placeholder – no new news.

AI Summary

InspireMD, Inc. (NSPR) filed an 8-K on June 13, 2024, to report under Regulation FD. The filing indicates that the company is not providing any new material information but is making available certain communications. No specific financial figures or new business developments were detailed in this particular filing.

Why It Matters

This filing serves as a notification to the market that InspireMD is not disclosing any new material information, which can be important for investors monitoring company communications.

Risk Assessment

Risk Level: low — This filing is procedural and does not contain new financial or operational information that would typically impact risk.

Key Players & Entities

FAQ

What is the purpose of this 8-K filing by InspireMD, Inc.?

The purpose of this 8-K filing is to report under Regulation FD, indicating that the company is not providing any new material information but is making certain communications available.

What is the trading symbol for InspireMD, Inc.?

The trading symbol for InspireMD, Inc. is NSPR.

On what date was this 8-K filing reported?

This 8-K filing was reported on June 13, 2024.

Does this filing disclose any new financial information?

No, this filing explicitly states under Item 7.01 Regulation FD that the company is not providing any new material information.

Where is InspireMD, Inc. incorporated?

InspireMD, Inc. is incorporated in Delaware.

Filing Stats: 496 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-06-13 16:06:05

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On June 13, 2024, InspireMD, Inc. (the "Company", "we", "us", or "our") made available an updated investor presentation. A copy of the presentation is attached hereto as Exhibit 99.1 and incorporated by reference in this Item 7.01. A copy of the presentation is also available on our website at https://www.inspiremd.com/en/investors/investor-relations/. The information contained in this Item 7.01, including in Exhibit 99.1 attached hereto, is "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, except to the extent such other filing specifically incorporates such information by reference.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits 99.1 InspireMD Investor Presentation June 2024 104 Cover Page Interactive Data File (formatted as inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INSPIREMD, INC. Date: June 13, 2024 By: /s/ Craig Shore Name: Craig Shore Title: Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing